Cyprus

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National

Download

Value (%)	Year	Type	Source
0.7 (0.67 - 0.72)	2019	Modelled	IHME
0.72 (0.70 - 0.75)	2018	Modelled	IHME
0.74 (0.71 - 0.76)	2017	Modelled	IHME
0.74 (0.72 - 0.76)	2016	Modelled	IHME
0.74 (0.72 - 0.77)	2015	Modelled	IHME
0.75 (0.72 - 0.77)	2014	Modelled	IHME
0.76 (0.73 - 0.78)	2013	Modelled	IHME
0.77 (0.74 - 0.79)	2012	Modelled	IHME
0.78 (0.75 - 0.81)	2011	Modelled	IHME
0.79 (0.77 - 0.82)	2010	Modelled	IHME
0.8 (0.78 - 0.83)	2009	Modelled	IHME
0.82 (0.79 - 0.84)	2008	Modelled	IHME
0.83 (0.81 - 0.86)	2007	Modelled	IHME
0.85 (0.82 - 0.87)	2006	Modelled	IHME
0.86 (0.84 - 0.89)	2005	Modelled	IHME
0.88 (0.85 - 0.90)	2004	Modelled	IHME
0.89 (0.87 - 0.92)	2003	Modelled	IHME
0.91 (0.89 - 0.94)	2002	Modelled	IHME
0.93 (0.90 - 0.96)	2001	Modelled	IHME
0.95 (0.92 - 0.98)	2000	Modelled	IHME
0.97 (0.94 - 1)	1999	Modelled	IHME
0.99 (0.96 - 1.02)	1998	Modelled	IHME
1.01 (0.98 - 1.04)	1997	Modelled	IHME
1.03 (1 - 1.06)	1996	Modelled	IHME
1.05 (1.02 - 1.08)	1995	Modelled	IHME
1.07 (1.04 - 1.10)	1994	Modelled	IHME
1.1 (1.06 - 1.13)	1993	Modelled	IHME
1.12 (1.09 - 1.15)	1992	Modelled	IHME
1.15 (1.11 - 1.18)	1991	Modelled	IHME
1.17 (1.13 - 1.21)	1990	Modelled	IHME
1.72 (1.18 - 2.49)	2015	Modelled	WHO

Showing out of

Children under-5 years

Download

Value (%)	Year	Type	Source
0.02 (0.01 - 0.02)	2019	Modelled	IHME
0.02 (0.02 - 0.02)	2018	Modelled	IHME
0.02 (0.02 - 0.02)	2017	Modelled	IHME
0.02 (0.02 - 0.02)	2016	Modelled	IHME
0.02 (0.01 - 0.02)	2015	Modelled	IHME
0.02 (0.02 - 0.02)	2014	Modelled	IHME
0.02 (0.02 - 0.03)	2013	Modelled	IHME
0.02 (0.02 - 0.03)	2012	Modelled	IHME
0.03 (0.02 - 0.03)	2011	Modelled	IHME
0.03 (0.02 - 0.03)	2010	Modelled	IHME
0.03 (0.02 - 0.04)	2009	Modelled	IHME
0.03 (0.03 - 0.04)	2008	Modelled	IHME
0.04 (0.03 - 0.05)	2007	Modelled	IHME
0.04 (0.03 - 0.05)	2006	Modelled	IHME
0.05 (0.04 - 0.05)	2005	Modelled	IHME
0.05 (0.04 - 0.06)	2004	Modelled	IHME
0.05 (0.04 - 0.06)	2003	Modelled	IHME
0.05 (0.04 - 0.06)	2002	Modelled	IHME
0.06 (0.05 - 0.07)	2001	Modelled	IHME
0.06 (0.05 - 0.07)	2000	Modelled	IHME
0.07 (0.06 - 0.08)	1999	Modelled	IHME
0.08 (0.06 - 0.09)	1998	Modelled	IHME
0.09 (0.07 - 0.11)	1997	Modelled	IHME
0.1 (0.08 - 0.12)	1996	Modelled	IHME
0.12 (0.09 - 0.14)	1995	Modelled	IHME
0.14 (0.11 - 0.16)	1994	Modelled	IHME
0.16 (0.13 - 0.19)	1993	Modelled	IHME
0.19 (0.15 - 0.22)	1992	Modelled	IHME
0.22 (0.18 - 0.26)	1991	Modelled	IHME
0.25 (0.20 - 0.30)	1990	Modelled	IHME
0.6 (0.37 - 0.98)	2015	Modelled	WHO

Showing out of

Technical notes

Number of people living with chronic HBV

National

Download

Value	Year	Type	Source
9,132 (8,826 - 9,423)	1990	Modelled	IHME
9,086 (8,794 - 9,364)	1991	Modelled	IHME
9,040 (8,755 - 9,297)	1992	Modelled	IHME
8,992 (8,720 - 9,243)	1993	Modelled	IHME
8,944 (8,664 - 9,194)	1994	Modelled	IHME
8,898 (8,618 - 9,168)	1995	Modelled	IHME
8,858 (8,586 - 9,108)	1996	Modelled	IHME
8,822 (8,548 - 9,075)	1997	Modelled	IHME
8,790 (8,517 - 9,043)	1998	Modelled	IHME
8,759 (8,484 - 9,023)	1999	Modelled	IHME
8,731 (8,451 - 8,998)	2000	Modelled	IHME
8,705 (8,443 - 8,963)	2001	Modelled	IHME
8,684 (8,428 - 8,937)	2002	Modelled	IHME
8,671 (8,416 - 8,923)	2003	Modelled	IHME
8,671 (8,420 - 8,928)	2004	Modelled	IHME
8,685 (8,428 - 8,950)	2005	Modelled	IHME
8,712 (8,456 - 8,966)	2006	Modelled	IHME
8,746 (8,486 - 9,004)	2007	Modelled	IHME
8,787 (8,510 - 9,051)	2008	Modelled	IHME
8,835 (8,548 - 9,105)	2009	Modelled	IHME
8,888 (8,584 - 9,169)	2010	Modelled	IHME
8,933 (8,642 - 9,223)	2011	Modelled	IHME
8,968 (8,691 - 9,256)	2012	Modelled	IHME
9,005 (8,725 - 9,304)	2013	Modelled	IHME
9,061 (8,773 - 9,370)	2014	Modelled	IHME
9,152 (8,856 - 9,462)	2015	Modelled	IHME
9,282 (8,992 - 9,564)	2016	Modelled	IHME
9,403 (9,098 - 9,711)	2017	Modelled	IHME
9,369 (9,068 - 9,671)	2018	Modelled	IHME
9,158 (8,842 - 9,457)	2019	Modelled	IHME

Showing out of

HBV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
1.23 (0.92 - 1.61)	2019	Modelled	IHME
1.22 (0.92 - 1.59)	2018	Modelled	IHME
1.2 (0.92 - 1.56)	2017	Modelled	IHME
1.2 (0.92 - 1.57)	2016	Modelled	IHME
1.21 (0.93 - 1.56)	2015	Modelled	IHME
1.2 (0.93 - 1.55)	2014	Modelled	IHME
1.19 (0.92 - 1.54)	2013	Modelled	IHME
1.18 (0.91 - 1.52)	2012	Modelled	IHME
1.18 (0.92 - 1.53)	2011	Modelled	IHME
1.2 (0.93 - 1.56)	2010	Modelled	IHME
1.21 (0.93 - 1.58)	2009	Modelled	IHME
1.22 (0.94 - 1.58)	2008	Modelled	IHME
1.24 (0.96 - 1.63)	2007	Modelled	IHME
1.26 (0.96 - 1.64)	2006	Modelled	IHME
1.27 (0.97 - 1.67)	2005	Modelled	IHME
1.28 (0.98 - 1.67)	2004	Modelled	IHME
1.32 (1 - 1.73)	2003	Modelled	IHME
1.38 (1.04 - 1.81)	2002	Modelled	IHME
1.43 (1.08 - 1.90)	2001	Modelled	IHME
1.51 (1.13 - 2.03)	2000	Modelled	IHME
1.6 (1.19 - 2.16)	1999	Modelled	IHME
1.7 (1.27 - 2.31)	1998	Modelled	IHME
1.79 (1.33 - 2.45)	1997	Modelled	IHME
1.87 (1.39 - 2.55)	1996	Modelled	IHME
1.92 (1.40 - 2.67)	1995	Modelled	IHME
1.93 (1.39 - 2.72)	1994	Modelled	IHME
1.96 (1.39 - 2.77)	1993	Modelled	IHME
1.96 (1.39 - 2.80)	1992	Modelled	IHME
1.94 (1.36 - 2.75)	1991	Modelled	IHME
1.92 (1.34 - 2.69)	1990	Modelled	IHME

Showing out of

Technical notes

HBV-related deaths

National

Download

Value	Year	Type	Source
16 (12 - 21)	2019	Modelled	IHME
16 (12 - 21)	2018	Modelled	IHME
15 (12 - 20)	2017	Modelled	IHME
15 (12 - 20)	2016	Modelled	IHME
15 (11 - 19)	2015	Modelled	IHME
15 (11 - 19)	2014	Modelled	IHME
14 (11 - 18)	2013	Modelled	IHME
14 (11 - 18)	2012	Modelled	IHME
14 (10 - 18)	2011	Modelled	IHME
13 (10 - 18)	2010	Modelled	IHME
13 (10 - 17)	2009	Modelled	IHME
13 (10 - 17)	2008	Modelled	IHME
13 (10 - 17)	2007	Modelled	IHME
13 (10 - 17)	2006	Modelled	IHME
13 (10 - 17)	2005	Modelled	IHME
13 (10 - 17)	2004	Modelled	IHME
13 (10 - 17)	2003	Modelled	IHME
13 (10 - 17)	2002	Modelled	IHME
13 (10 - 18)	2001	Modelled	IHME
14 (10 - 19)	2000	Modelled	IHME
14 (11 - 20)	1999	Modelled	IHME
15 (11 - 21)	1998	Modelled	IHME
16 (12 - 21)	1997	Modelled	IHME
16 (12 - 22)	1996	Modelled	IHME
16 (12 - 23)	1995	Modelled	IHME
16 (12 - 23)	1994	Modelled	IHME
16 (11 - 23)	1993	Modelled	IHME
16 (11 - 23)	1992	Modelled	IHME
15 (11 - 22)	1991	Modelled	IHME
15 (10 - 21)	1990	Modelled	IHME
48	2016	Modelled	WHO

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HBV

National

Download

Value (%)	Year	Type	Source
11 (8 - 17)	2019	Modelled	IHME
11 (8 - 16)	2018	Modelled	IHME
11 (8 - 17)	2017	Modelled	IHME
11 (8 - 16)	2016	Modelled	IHME
11 (8 - 16)	2015	Modelled	IHME
11 (8 - 16)	2014	Modelled	IHME
12 (8 - 17)	2013	Modelled	IHME
12 (8 - 17)	2012	Modelled	IHME
12 (8 - 17)	2011	Modelled	IHME
12 (8 - 17)	2010	Modelled	IHME
12 (8 - 17)	2009	Modelled	IHME
12 (8 - 17)	2008	Modelled	IHME
12 (8 - 17)	2007	Modelled	IHME
12 (8 - 17)	2006	Modelled	IHME
12 (8 - 18)	2005	Modelled	IHME
12 (9 - 18)	2004	Modelled	IHME
13 (9 - 18)	2003	Modelled	IHME
13 (9 - 18)	2002	Modelled	IHME
13 (9 - 19)	2001	Modelled	IHME
13 (9 - 19)	2000	Modelled	IHME
13 (9 - 19)	1999	Modelled	IHME
14 (10 - 19)	1998	Modelled	IHME
14 (10 - 20)	1997	Modelled	IHME
14 (10 - 20)	1996	Modelled	IHME
14 (10 - 20)	1995	Modelled	IHME
14 (10 - 20)	1994	Modelled	IHME
14 (10 - 20)	1993	Modelled	IHME
14 (10 - 20)	1992	Modelled	IHME
14 (10 - 20)	1991	Modelled	IHME
14 (10 - 20)	1990	Modelled	IHME

Showing out of

Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants

Download

Value (%)	Year	Type	Source
97	2018	Survey/reported	WHO/UNICEF
97	2017	Survey/reported	WHO/UNICEF
97	2016	Survey/reported	WHO/UNICEF
97	2015	Survey/reported	WHO/UNICEF
96	2014	Survey/reported	WHO/UNICEF
96	2013	Survey/reported	WHO/UNICEF
96	2012	Survey/reported	WHO/UNICEF
96	2011	Survey/reported	WHO/UNICEF
96	2010	Survey/reported	WHO/UNICEF
96	2009	Survey/reported	WHO/UNICEF
93	2008	Survey/reported	WHO/UNICEF
93	2007	Survey/reported	WHO/UNICEF
93	2006	Survey/reported	WHO/UNICEF
88	2005	Survey/reported	WHO/UNICEF
88	2004	Survey/reported	WHO/UNICEF
88	2003	Survey/reported	WHO/UNICEF
88	2002	Survey/reported	WHO/UNICEF
89	2001	Survey/reported	WHO/UNICEF
89	2000	Survey/reported	WHO/UNICEF
89	1999	Survey/reported	WHO/UNICEF
88	1998	Survey/reported	WHO/UNICEF
88	1997	Survey/reported	WHO/UNICEF
88	1996	Survey/reported	WHO/UNICEF
68	1995	Survey/reported	WHO/UNICEF
54	1994	Survey/reported	WHO/UNICEF
41	1993	Survey/reported	WHO/UNICEF
27	1992	Survey/reported	WHO/UNICEF
20	1991	Survey/reported	WHO/UNICEF
94	2019	Survey/reported	WHO/UNICEF

Showing out of

Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
1	2017	Survey/reported	EMCDDA, 2019
0 (0 - 0)	2015	Survey/reported	EMCDDA, 2017

Showing out of

Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
18	2017	Survey/reported	EMCDDA, 2019

HBV National Action Plan

Source;

HBV elimination goal

Source:

Year of HBV elimination goal

2030

Source:

HBV testing policy

No policy

Source:

HepB birth dose policy

Source: WHO

Eligible for HBV generic medicines

Source: MPP

HCV National Action Plan

Source:

HCV elimination goal

Source:

Year of HCV elimination goal

2030

Source:

HCV testing policy

No policy

Source:

Eligible for HCV generic medicines

Source: MPP

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Yes

Source: Harm Reduction International

NSP in at least one prison

Source: Harm Reduction International

OST in at least one prison

Yes

Source: Harm Reduction International

% of substance use disorder facilities offering hepatitis testing

Some (11-30%)

Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National

Download

Value (%)	Year	Type	Source
0.64 (0.52 - 0.79)	2019	Modelled	IHME
0.64 (0.52 - 0.79)	2018	Modelled	IHME
0.64 (0.52 - 0.79)	2017	Modelled	IHME
0.62 (0.51 - 0.77)	2016	Modelled	IHME
0.61 (0.50 - 0.75)	2015	Modelled	IHME
0.61 (0.50 - 0.75)	2014	Modelled	IHME
0.61 (0.50 - 0.75)	2013	Modelled	IHME
0.61 (0.50 - 0.75)	2012	Modelled	IHME
0.61 (0.49 - 0.75)	2011	Modelled	IHME
0.61 (0.49 - 0.74)	2010	Modelled	IHME
0.59 (0.48 - 0.73)	2009	Modelled	IHME
0.56 (0.46 - 0.69)	2008	Modelled	IHME
0.53 (0.44 - 0.64)	2007	Modelled	IHME
0.5 (0.42 - 0.61)	2006	Modelled	IHME
0.49 (0.40 - 0.59)	2005	Modelled	IHME
0.49 (0.40 - 0.59)	2004	Modelled	IHME
0.49 (0.40 - 0.59)	2003	Modelled	IHME
0.49 (0.40 - 0.58)	2002	Modelled	IHME
0.48 (0.40 - 0.58)	2001	Modelled	IHME
0.48 (0.40 - 0.58)	2000	Modelled	IHME
0.48 (0.40 - 0.59)	1999	Modelled	IHME
0.48 (0.39 - 0.58)	1998	Modelled	IHME
0.48 (0.39 - 0.58)	1997	Modelled	IHME
0.48 (0.39 - 0.58)	1996	Modelled	IHME
0.48 (0.39 - 0.58)	1995	Modelled	IHME
0.49 (0.40 - 0.59)	1994	Modelled	IHME
0.51 (0.41 - 0.61)	1993	Modelled	IHME
0.53 (0.43 - 0.65)	1992	Modelled	IHME
0.57 (0.46 - 0.70)	1991	Modelled	IHME
0.6 (0.49 - 0.75)	1990	Modelled	IHME

Showing out of

Technical notes

Prevalence of anti-HCV

National

Download

Value (%)	Year	Type	Source
0.6 (0.50 - 1.90)	2014	Survey/reported	Gower et al, 2014

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
49.7 (44.40 - 55)	2014	Modelled	Degenhardt L et al, 2017
47.6 (36.40 - 58.90)	2013	Survey/reported	EMCDDA

Showing out of

Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National

Download

Value	Year	Type	Source
4,690 (3,799 - 5,836)	1990	Modelled	IHME
4,485 (3,646 - 5,553)	1991	Modelled	IHME
4,296 (3,489 - 5,212)	1992	Modelled	IHME
4,145 (3,378 - 5,033)	1993	Modelled	IHME
4,059 (3,323 - 4,938)	1994	Modelled	IHME
4,067 (3,303 - 4,948)	1995	Modelled	IHME
4,134 (3,363 - 5,011)	1996	Modelled	IHME
4,206 (3,434 - 5,091)	1997	Modelled	IHME
4,281 (3,502 - 5,188)	1998	Modelled	IHME
4,359 (3,575 - 5,289)	1999	Modelled	IHME
4,440 (3,644 - 5,353)	2000	Modelled	IHME
4,524 (3,714 - 5,456)	2001	Modelled	IHME
4,615 (3,785 - 5,556)	2002	Modelled	IHME
4,714 (3,871 - 5,698)	2003	Modelled	IHME
4,823 (3,957 - 5,838)	2004	Modelled	IHME
4,943 (4,054 - 5,990)	2005	Modelled	IHME
5,183 (4,285 - 6,267)	2006	Modelled	IHME
5,589 (4,614 - 6,765)	2007	Modelled	IHME
6,065 (4,977 - 7,436)	2008	Modelled	IHME
6,504 (5,313 - 7,984)	2009	Modelled	IHME
6,788 (5,515 - 8,351)	2010	Modelled	IHME
6,949 (5,652 - 8,580)	2011	Modelled	IHME
7,098 (5,802 - 8,750)	2012	Modelled	IHME
7,241 (5,896 - 8,906)	2013	Modelled	IHME
7,386 (6,022 - 9,086)	2014	Modelled	IHME
7,538 (6,122 - 9,274)	2015	Modelled	IHME
7,816 (6,384 - 9,663)	2016	Modelled	IHME
8,119 (6,596 - 10,046)	2017	Modelled	IHME
8,315 (6,780 - 10,191)	2018	Modelled	IHME
8,468 (6,863 - 10,372)	2019	Modelled	IHME

Showing out of

HCV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
3.79 (3 - 4.72)	2019	Modelled	IHME
3.73 (2.93 - 4.62)	2018	Modelled	IHME
3.67 (2.91 - 4.53)	2017	Modelled	IHME
3.67 (2.92 - 4.54)	2016	Modelled	IHME
3.67 (2.95 - 4.56)	2015	Modelled	IHME
3.62 (2.90 - 4.50)	2014	Modelled	IHME
3.58 (2.87 - 4.41)	2013	Modelled	IHME
3.52 (2.82 - 4.31)	2012	Modelled	IHME
3.5 (2.82 - 4.32)	2011	Modelled	IHME
3.5 (2.80 - 4.34)	2010	Modelled	IHME
3.46 (2.76 - 4.32)	2009	Modelled	IHME
3.45 (2.75 - 4.33)	2008	Modelled	IHME
3.45 (2.73 - 4.35)	2007	Modelled	IHME
3.43 (2.69 - 4.31)	2006	Modelled	IHME
3.38 (2.67 - 4.26)	2005	Modelled	IHME
3.31 (2.63 - 4.20)	2004	Modelled	IHME
3.3 (2.59 - 4.22)	2003	Modelled	IHME
3.33 (2.62 - 4.27)	2002	Modelled	IHME
3.34 (2.62 - 4.29)	2001	Modelled	IHME
3.38 (2.62 - 4.40)	2000	Modelled	IHME
3.42 (2.63 - 4.45)	1999	Modelled	IHME
3.42 (2.61 - 4.46)	1998	Modelled	IHME
3.4 (2.58 - 4.45)	1997	Modelled	IHME
3.41 (2.56 - 4.46)	1996	Modelled	IHME
3.43 (2.58 - 4.51)	1995	Modelled	IHME
3.46 (2.56 - 4.53)	1994	Modelled	IHME
3.52 (2.57 - 4.67)	1993	Modelled	IHME
3.53 (2.54 - 4.72)	1992	Modelled	IHME
3.49 (2.49 - 4.66)	1991	Modelled	IHME
3.45 (2.46 - 4.58)	1990	Modelled	IHME

Showing out of

Technical notes

HCV-related deaths

National

Download

Value	Year	Type	Source
50 (39 - 62)	2019	Modelled	IHME
48 (38 - 60)	2018	Modelled	IHME
47 (37 - 58)	2017	Modelled	IHME
46 (37 - 57)	2016	Modelled	IHME
45 (36 - 56)	2015	Modelled	IHME
44 (35 - 54)	2014	Modelled	IHME
43 (34 - 53)	2013	Modelled	IHME
41 (33 - 50)	2012	Modelled	IHME
40 (32 - 49)	2011	Modelled	IHME
39 (31 - 49)	2010	Modelled	IHME
38 (30 - 47)	2009	Modelled	IHME
37 (30 - 47)	2008	Modelled	IHME
36 (29 - 46)	2007	Modelled	IHME
35 (28 - 44)	2006	Modelled	IHME
34 (27 - 43)	2005	Modelled	IHME
33 (26 - 42)	2004	Modelled	IHME
32 (25 - 41)	2003	Modelled	IHME
32 (25 - 41)	2002	Modelled	IHME
31 (24 - 40)	2001	Modelled	IHME
31 (24 - 40)	2000	Modelled	IHME
31 (24 - 40)	1999	Modelled	IHME
30 (23 - 40)	1998	Modelled	IHME
30 (23 - 39)	1997	Modelled	IHME
29 (22 - 38)	1996	Modelled	IHME
29 (22 - 38)	1995	Modelled	IHME
29 (21 - 38)	1994	Modelled	IHME
29 (21 - 38)	1993	Modelled	IHME
29 (20 - 38)	1992	Modelled	IHME
28 (20 - 37)	1991	Modelled	IHME
27 (19 - 36)	1990	Modelled	IHME
38	2016	Modelled	WHO

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HCV

National

Download

Value (%)	Year	Type	Source
40 (30 - 50)	2019	Modelled	IHME
40 (30 - 50)	2018	Modelled	IHME
40 (30 - 50)	2017	Modelled	IHME
40 (30 - 50)	2016	Modelled	IHME
40 (30 - 50)	2015	Modelled	IHME
40 (29 - 50)	2014	Modelled	IHME
39 (29 - 50)	2013	Modelled	IHME
39 (29 - 49)	2012	Modelled	IHME
39 (29 - 49)	2011	Modelled	IHME
39 (29 - 48)	2010	Modelled	IHME
38 (29 - 48)	2009	Modelled	IHME
38 (29 - 48)	2008	Modelled	IHME
38 (28 - 48)	2007	Modelled	IHME
38 (28 - 48)	2006	Modelled	IHME
37 (27 - 47)	2005	Modelled	IHME
37 (27 - 47)	2004	Modelled	IHME
37 (27 - 47)	2003	Modelled	IHME
37 (27 - 47)	2002	Modelled	IHME
37 (27 - 47)	2001	Modelled	IHME
37 (27 - 47)	2000	Modelled	IHME
37 (27 - 47)	1999	Modelled	IHME
37 (27 - 47)	1998	Modelled	IHME
37 (27 - 47)	1997	Modelled	IHME
37 (27 - 48)	1996	Modelled	IHME
37 (28 - 48)	1995	Modelled	IHME
38 (28 - 48)	1994	Modelled	IHME
38 (28 - 48)	1993	Modelled	IHME
38 (28 - 48)	1992	Modelled	IHME
38 (28 - 48)	1991	Modelled	IHME
38 (28 - 48)	1990	Modelled	IHME

Showing out of

Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
1	2017	Survey/reported	EMCDDA, 2019
0 (0 - 0)	2015	Survey/reported	EMCDDA, 2017

Showing out of

Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
18	2017	Survey/reported	EMCDDA, 2019

HBV National Action Plan

Source;

HBV elimination goal

Source:

Year of HBV elimination goal

2030

Source:

HBV testing policy

No policy

Source:

HepB birth dose policy

Source: WHO

Eligible for HBV generic medicines

Source: MPP

HCV National Action Plan

Source:

HCV elimination goal

Source:

Year of HCV elimination goal

2030

Source:

HCV testing policy

No policy

Source:

Eligible for HCV generic medicines

Source: MPP

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Yes

Source: Harm Reduction International

NSP in at least one prison

Source: Harm Reduction International

OST in at least one prison

Yes

Source: Harm Reduction International

% of substance use disorder facilities offering hepatitis testing

Some (11-30%)

Source: WHO

Overview

HBV elimination goal

Year of goal

2030

HCV elimination goal

Year of goal

2030

Prevalence (national)

Modelled

Survey/surveillance

No data available

Hepatitis related deaths (national)

Modelled

Survey/surveillance

No data available

HBV chart

Modelled

Survey/surveillance

No data available

HCV chart

Prevalence < 5

HBV

0.02 (%)

2019, latest modelled

(0.01 - 0.02(%))

IHME

Prevalence PWID

HCV

47.60 (%)

2013, survey/surveillance

(36.40 - 58.90(%))

EMCDDA

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV

2017

EMCDDA, 2019

Eligible for HBV generic medicines

Eligible for HCV generic medicines

Action plan

National Strategy to Eliminate Viral Hepatitis in Cyprus 2019-2024

2018

Republic of Cyprus Ministry of Health

View all

Elimination champion

Dr. Petros Katsioloudes

Over 3 years, he involved all stakeholders, especially the patients in Cyprus to receive Ministry approval for a National Action Plan for Eradication of Hepatitis C 2019-2024.